{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:40:21Z","timestamp":1765280421027,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018568","name":"Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","doi-asserted-by":"publisher","award":["210713116901849","210729156901797"],"award-info":[{"award-number":["210713116901849","210729156901797"]}],"id":[{"id":"10.13039\/501100018568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272945"],"award-info":[{"award-number":["82272945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Guangdong Province Department of Education","doi-asserted-by":"publisher","award":["2021KCXTD005"],"award-info":[{"award-number":["2021KCXTD005"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007421","name":"Li Ka Shing Foundation","doi-asserted-by":"publisher","award":["2020LKSFG07B"],"award-info":[{"award-number":["2020LKSFG07B"]}],"id":[{"id":"10.13039\/100007421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clinre.2024.102318","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:36:13Z","timestamp":1710135373000},"page":"102318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data"],"prefix":"10.1016","volume":"48","author":[{"given":"Zhi-Mao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-E.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai-Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-4292","authenticated-orcid":false,"given":"Li-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102318_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9836256","article-title":"Onco-multi-omics approach: a new frontier in cancer research","volume":"2018","author":"Chakraborty","year":"2018","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.clinre.2024.102318_bib0002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to Radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0004","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00330-019-06347-w","article-title":"Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules","volume":"30","author":"Mokrane","year":"2020","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192002","article-title":"Radiomic features analysis in computed tomography images of lung nodule classification","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.clinre.2024.102318_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5152\/dir.2018.17369","article-title":"Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy","volume":"24","author":"Sun","year":"2018","journal-title":"Diagn Interv Radiol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2016.10.021","article-title":"The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy","volume":"121","author":"Wang","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-020-01699-w","article-title":"Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy","volume":"16","author":"Zeng","year":"2021","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0009","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jmri.27140","article-title":"Radiomic features of primary rectal cancers on baseline T(2) -weighted MRI are associated with pathologic complete response to neoadjuvant chemoradiation: a multisite Study","volume":"52","author":"Antunes","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.clinre.2024.102318_bib0010","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.clinre.2024.102318_bib0011","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ijrobp.2021.06.033","article-title":"3D deep learning model for the pretreatment evaluation of treatment response in esophageal carcinoma: a prospective study (ChiCTR2000039279)","volume":"111","author":"Li","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13014-020-01692-3","article-title":"A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer","volume":"15","author":"Luo","year":"2020","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0013","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mas.20356","article-title":"Cancer proteomics","volume":"31","author":"Tan","year":"2012","journal-title":"Mass Spectrom Rev"},{"issue":"4","key":"10.1016\/j.clinre.2024.102318_bib0014","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/acs.jproteome.0c00641","article-title":"Multiplatform approach for plasma proteomics: complementarity of olink proximity extension assay technology to mass spectrometry-based protein profiling","volume":"20","author":"Petrera","year":"2021","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-021-00266-z","article-title":"Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark Res"},{"issue":"13","key":"10.1016\/j.clinre.2024.102318_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133077","article-title":"Development of a multiprotein classifier for the detection of early stage ovarian cancer","volume":"14","author":"Boylan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinre.2024.102318_bib0018","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fonc.2019.01150","article-title":"Multi-platform affinity proteomics identify proteins linked to metastasis and immune suppression in ovarian cancer plasma","volume":"9","author":"Graumann","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0019","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41416-020-01200-0","article-title":"Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer","volume":"124","author":"Liu","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.clinre.2024.102318_bib0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0021","first-page":"12715","article-title":"ESCC ATLAS: a population wide compendium of biomarkers for","volume":"8","author":"Tungekar","year":"2018","journal-title":"Esophageal Squamous Cell Carcinoma. Sci Rep"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0022","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.athoracsur.2003.10.098","article-title":"Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening","volume":"77","author":"Wang","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0023","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/annonc\/mdy498","article-title":"Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS","volume":"30","author":"Muro","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0024","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clinre.2024.102318_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.21147\/j.issn.1000-9604.2020.03.01","article-title":"Current status of esophageal cancer treatment","volume":"32","author":"Triantafyllou","year":"2020","journal-title":"Chin J Cancer Res"},{"issue":"8","key":"10.1016\/j.clinre.2024.102318_bib0026","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/15384047.2019.1598760","article-title":"Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma","volume":"20","author":"Jing","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clinre.2024.102318_bib0027","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3389\/fonc.2020.01727","article-title":"Understanding esophageal cancer: the challenges and opportunities for the next decade","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11547-019-01081-1","article-title":"Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma","volume":"125","author":"Sun","year":"2020","journal-title":"Radiol Med"},{"issue":"6","key":"10.1016\/j.clinre.2024.102318_bib0029","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.3892\/ol.2015.3779","article-title":"Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging","volume":"10","author":"Lei","year":"2015","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.clinre.2024.102318_bib0030","first-page":"1410","article-title":"Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma","volume":"125","author":"Yan","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.clinre.2024.102318_bib0031","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3892\/or.2015.4499","article-title":"Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma","volume":"35","author":"Dong","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clinre.2024.102318_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinform Biol Insights"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0033","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0034","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.clinre.2024.102318_bib0036","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22926.1","article-title":"Recent advances in treating oesophageal cancer","volume":"9","author":"Harada","year":"2020","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.clinre.2024.102318_bib0037","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.suc.2021.03.006","article-title":"Chemoradiation therapy as definitive treatment of esophageal cancer","volume":"101","author":"Wang","year":"2021","journal-title":"Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0038","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/0284186X.2021.1902564","article-title":"Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG survey","volume":"60","author":"Li","year":"2021","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.clinre.2024.102318_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124366","article-title":"Overexpression of the novel senescence marker beta-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence","volume":"10","author":"Wagner","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12032-011-9851-x","article-title":"Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose","volume":"29","author":"Liang","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.clinre.2024.102318_bib0041","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2021.10.042","article-title":"Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases","volume":"525","author":"Su","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2024.102318_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7120979","article-title":"PTH1R-CaSR Cross talk: new treatment options for breast cancer osteolytic bone metastases","volume":"2018","author":"Yang","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"21","key":"10.1016\/j.clinre.2024.102318_bib0043","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-18-1749","article-title":"p63-Dependent dickkopf3 expression promotes esophageal cancer cell proliferation via CKAP4","volume":"78","author":"Kajiwara","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2024.102318_bib0044","article-title":"DKK3\/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer","author":"Katase","year":"2022","journal-title":"Oral Dis"},{"key":"10.1016\/j.clinre.2024.102318_bib0045","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.921002","article-title":"Upregulation of FAM3b promotes cisplatin resistance in gastric cancer by inducing epithelial-mesenchymal transition","volume":"26","author":"Song","year":"2020","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1016\/j.clinre.2024.102318_bib0046","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jcmm.14040","article-title":"FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition","volume":"23","author":"He","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.clinre.2024.102318_bib0047","doi-asserted-by":"crossref","first-page":"e8299","DOI":"10.7717\/peerj.8299","article-title":"Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer","volume":"7","author":"Wu","year":"2019","journal-title":"PeerJ"},{"issue":"5","key":"10.1016\/j.clinre.2024.102318_bib0048","first-page":"981","article-title":"Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer","volume":"16","author":"Chong","year":"2006","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.clinre.2024.102318_bib0049","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-023-01089-0","article-title":"Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model","volume":"23","author":"Cheng","year":"2023","journal-title":"BMC Med Imaging"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:41Z","timestamp":1761896141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2210740124000391"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102318","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102318"}}